Core Viewpoint - A class action lawsuit has been filed against Quantum Corporation (QMCO) for allegedly making false statements regarding its revenue recognition and financial statements, leading to investor losses during the specified period [3][7]. Allegation Details - The lawsuit claims that Quantum Corporation improperly recognized revenue for the fiscal year ending March 31, 2025 [3]. - It is stated that Quantum will need to restate its financial statements for the fiscal third quarter ending December 31, 2024 [3]. - The defendants' statements about the company's business, operations, and prospects are alleged to be materially false and misleading [3]. Next Steps for Investors - Investors who purchased Quantum shares and suffered losses are encouraged to contact the law firm for more information and to discuss their rights [4][7]. - The deadline for investors to apply to be appointed as lead plaintiff in the lawsuit is November 3, 2025 [7]. About the Law Firm - Bragar Eagel & Squire, P.C. is a nationally recognized law firm that represents individual and institutional investors in complex litigation [5]. - The firm has offices in New York, California, and South Carolina, and specializes in commercial and securities litigation [5].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Quantum Corporation securities between November 15, 2024, and August 18, 2025, of the upcoming lead plaintiff deadline for a securities class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased Quantum Corporation securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by November 3, 2025 [3]. - The lawsuit alleges that Quantum Corporation made false or misleading statements regarding its revenue recognition and will need to restate its financial statements for the fiscal third quarter ended December 31, 2024 [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements, including the largest securities class action settlement against a Chinese company at the time [4]. - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4].

Accessibility StatementSkip Navigation HOBOKEN, N.J., Oct. 31, 2025 /PRNewswire/ -- Quantum Computing Inc. ("QCi" or the "Company") (Nasdaq: QUBT), an innovative, integrated photonics and quantum optics technology company, today announced that the Company will host a conference call and webcast on Friday, November 14, 2025 at 4:30 p.m. Eastern Time to review the Company's operational progress for the third quarter ended September 30, 2025. The Company will release its third quarter 2025 financial results ...

Core Insights - The article discusses the potential downturn for quantum computing stocks, highlighting that historical valuation metrics indicate a significant reversal may be imminent for companies like IonQ, Rigetti Computing, D-Wave Quantum, and Quantum Computing Inc. [1][4][18] Industry Overview - Quantum computing is emerging as a transformative technology, with applications across various sectors, including drug development and AI optimization [6][10]. - The technology is still in its infancy, and widespread commercialization is not yet evident, suggesting that it may take years for businesses to realize returns on investments in quantum computing [11]. Company Performance - Over the past year, IonQ's stock has increased by 270%, while Rigetti, D-Wave, and Quantum Computing Inc. have seen gains of 3,220%, 3,270%, and 1,340%, respectively [4]. - Current market capitalizations for these companies are significant, with IonQ at $21 billion and Rigetti at $14 billion [8][16]. Valuation Metrics - The price-to-sales (P/S) ratio is identified as a more relevant valuation metric for early-stage companies like those in quantum computing, as traditional price-to-earnings (P/E) ratios are less applicable due to negative earnings [14]. - Historical data shows that leading companies in emerging technologies have peaked at P/S ratios between 31 and 43, while current P/S ratios for quantum computing stocks are projected to be much higher, ranging from 69 to 352 by 2027 [15][17][19]. - This suggests that the current valuations of quantum computing stocks are unsustainable, indicating a potential for significant price corrections in the future [18].

Huang's latest vote of confidence in quantum computing has reassured investors in the sector—and also provided clues about how the company might fit into the ecosystem in years to come. ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Quantum Corporation To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Quantum Corporation between November 15, 2024 and August 18, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Oct. 30, 2025 ( ...

Core Insights - Quantum Computing Inc. (QCi) has seen its stock price increase over 1,000% in the past year, despite struggling with sales [2][8] - The company has made significant advancements in quantum technology, particularly using photons for quantum machines, which offer advantages in data transmission and cybersecurity [5][6] - QCi's financial situation shows a stark contrast between rising operating expenses and minimal revenue, leading to a precarious financial outlook [9][14] Company Overview - Quantum Computing Inc. specializes in quantum computing technology, focusing on photonic systems that allow for long-distance quantum data transmission and enhanced cybersecurity [5][6] - The company has secured contracts with notable clients, including a major U.S. bank and NASA, indicating some market traction [7] Financial Performance - In Q2, QCi reported sales of $61,000, a decline from $183,000 in the previous year, while operating expenses surged to $10.2 million [8][9] - The company executed an equity offering expected to raise approximately $750 million, increasing its cash position to $1.55 billion [9][10] - Total capital raised since November 2024 amounts to $1.64 billion, positioning QCi with a strong balance sheet compared to its competitors [10] Market Position - QCi's forward price-to-sales (P/S) ratio is significantly higher than its competitors, indicating a potentially overvalued stock [12][14] - The company has yet to demonstrate a consistent revenue stream, raising concerns about its ability to capture market share despite promising technology [14][15] Future Outlook - The company plans to utilize its cash reserves for acquisitions, expanding its sales force, and increasing production capabilities, which may provide a buffer for future operations [11] - Investors are advised to monitor upcoming quarterly earnings reports for signs of improved customer traction and sales growth before making investment decisions [15]

Core Viewpoint - Quantum BioPharma Ltd. is conducting a non-brokered private placement of up to 30 Class A Multiple Voting Shares at a price of $25 per share, aiming for gross proceeds of up to $750 million, primarily to enhance voting rights and for general working capital purposes [1][2]. Group 1: Offering Details - The private placement is expected to be fully subscribed by entities controlled by Zeeshan Saeed and Anthony Durkacz, existing holders of Class A Multiple Voting Shares [1][3]. - If fully subscribed, the voting rights attached to Class A Multiple Voting Shares will increase to 75.27%, nearly restoring the percentage to that at the time of the company's IPO in 2018 [2]. - The board of directors unanimously approved the Offering, excluding Saeed and Durkacz from discussions due to their interests [2]. Group 2: Related Party Transactions - The Offering involves related-party transactions as it is anticipated that Xorax Family Trust and Fortius Research and Trading Corp. will purchase all Class A Multiple Voting Shares issued [3]. - The transaction is expected to be exempt from formal valuation and minority shareholder approval requirements under MI 61-101, as the fair market value will not exceed 25% of the company's market capitalization [3]. Group 3: Shareholder Structure - Prior to a recent transfer, the Transferor and Joint Actors held approximately 50% of the outstanding Class A Multiple Voting Shares and 24.85% of the voting rights attached to all voting securities [7]. - Following the transfer of 77,000 Class B Subordinate Voting Shares, the ownership structure changed, with the Transferor and Joint Actors now holding approximately 23.77% of the voting rights [8]. Group 4: Company Overview - Quantum BioPharma focuses on developing innovative biopharmaceutical solutions for neurodegenerative and metabolic disorders, with its lead compound, Lucid-MS, aimed at treating multiple sclerosis [12]. - The company retains a 20.10% ownership in Unbuzzd Wellness Inc., which includes a royalty agreement for sales from its product unbuzzd™ [12].

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Quantum (QMCO) To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Quantum between November 15, 2024, and August 18, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Oct. 29, 2025 (GLOBE NEWSWIRE) -- What’s Happening ...

Core Insights - Energy Plug Technologies Corp. has secured a pre-order for 20 units of its 261 kWh Battery Energy Storage System (ESS) from an existing client, indicating strong market confidence in the product [1][5] - The new ESS is co-developed with SEETEL New Energy, Quantum eMotion Corp., and Malahat Battery Technologies, with expected delivery in early 2026 pending UL certification [2] - The global Energy Storage Systems market is projected to reach approximately US $512.4 billion by 2030, with a compound annual growth rate of about 11% [6] Company Developments - Energy Plug's 261 kWh ESS is designed to work alongside diesel generators, providing a hybrid solution that enhances efficiency, reliability, and environmental performance for off-grid power needs [3][5] - The company is expanding its portfolio of modular and mobile energy systems to meet the increasing demand for clean and secure power solutions across various sectors, including construction and defense [5] Product Advantages - The hybrid ESS offers several key advantages, including intelligent load management for fuel efficiency, lower emissions, enhanced reliability, operational flexibility, and extended equipment lifespan [7] - The system is engineered to support mission-critical operations by providing uninterrupted power during variable load conditions [7] Industry Context - The expansion of battery and grid-scale storage is crucial for the global energy transition, particularly as renewable energy integration and decentralized power systems gain momentum [8]